Key papers in Cardiology and Cardiovascular Medicine
Pofolia’s corpus holds 77 papers from the Cardiology and Cardiovascular Medicine subfield (2012–2025). The list below starts with the most cited.
Most cited
Ranked by citation count. Because citations accumulate over time, this list naturally leans towards work published a few years ago; for where the field is now, see “recently added”.
Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
PubMed · 2021 · 19,548 citations
This is a corrigendum, a correction to the previously published 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
2013 ESH/ESC Guidelines for the management of arterial hypertension
European Heart Journal · 2013 · Q1 · SJR 5.00 · FWCI 882.48 · 13,682 citations · Open access
The 2013 ESH/ESC Guidelines offer recommendations for managing arterial hypertension, emphasizing their role as a guide for clinical judgment rather than a rigid rulebook.
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
European Heart Journal · 2021 · Q1 · SJR 5.00 · FWCI 1282.53 · 13,147 citations · Open access
These guidelines provide the European Society of Cardiology's (ESC) recommendations for diagnosing and treating heart failure, based on current scientific evidence.
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
The Nephron journals/Nephron journals · 2016 · Q2 · FWCI 726.68 · 11,736 citations
The benefit of continuing ACE inhibitors (ACEi) or angiotensin II receptor blockers (ARBs) in advanced chronic kidney disease (CKD) with an estimated GFR (eGFR) below 30 ml/min/1.73 m2 remains uncertain, with no clear evidence of cardiovascular risk reduction in this population.
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
Cerebrovascular Diseases · 2014 · Q2 · FWCI 186.84 · 11,558 citations · Open access
Short-term (≤3 months) dual antiplatelet therapy with aspirin and clopidogrel significantly reduces stroke recurrence and major vascular events by 31% and 30% respectively, without increasing bleeding risk, compared to single antiplatelet therapy.
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
European Heart Journal · 2016 · Q1 · SJR 5.00 · FWCI 757.84 · 11,536 citations · Open access
The 2016 European Society of Cardiology (ESC) guidelines provide updated recommendations for diagnosing and treating acute and chronic heart failure.
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Journal of the American College of Cardiology · 2020 · Q1 · SJR 8.00 · FWCI 644.27 · 11,235 citations
Cardiovascular diseases (CVDs) are the leading global cause of death and disability, with prevalent cases nearly doubling from 271 million in 1990 to 523 million in 2019.
2018 ESC/ESH Guidelines for the management of arterial hypertension
European Heart Journal · 2018 · Q1 · SJR 5.00 · FWCI 708.55 · 10,478 citations · Open access
These guidelines provide updated evidence-based recommendations for health professionals to manage arterial hypertension in individual patients.
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
European Heart Journal · 2020 · Q1 · SJR 5.00 · FWCI 837.05 · 9,979 citations
These guidelines provide updated recommendations for the diagnosis and management of atrial fibrillation, developed in collaboration with EACTS.
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
European Heart Journal · 2017 · Q1 · SJR 5.00 · FWCI 540.33 · 9,797 citations · Open access
These updated European Society of Cardiology (ESC) guidelines provide a comprehensive summary and evaluation of current evidence to assist health professionals in managing ST-segment elevation acute myocardial infarction (STEMI).
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Circulation · 2020 · Q1 · SJR 8.00 · FWCI 957.60 · 9,395 citations · Open access
This annual report provides the latest statistics on heart disease, stroke, and related risk factors in the United States, consolidating data on core health behaviors, clinical conditions, and outcomes.
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
European Heart Journal · 2012 · Q1 · SJR 5.00 · FWCI 427.90 · 8,522 citations · Open access
These 2012 guidelines consolidate evidence for cardiovascular disease (CVD) prevention, updating recommendations for risk assessment, lifestyle interventions, and pharmacological treatments.
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
European Heart Journal - Cardiovascular Imaging · 2015 · Q1 · SJR 2.00 · FWCI 309.04 · 8,358 citations · Open access
Updated guidelines for cardiac chamber quantification by echocardiography in adults have been released, incorporating recent technological advancements and larger datasets.
Heart disease and stroke statistics--2015 update: a report from the American Heart Association.
PubMed · 2015 · FWCI 969.90 · 8,341 citations
The 2015 update from the American Heart Association presents comprehensive statistics on heart disease and stroke, highlighting their significant impact on public health and healthcare systems.
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
European Heart Journal · 2015 · Q1 · SJR 5.00 · FWCI 630.07 · 8,324 citations · Open access
These guidelines provide updated recommendations for managing acute coronary syndromes (ACS) in patients without persistent ST-segment elevation (NSTE-ACS). They emphasize early risk stratification and tailored treatment strategies.
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
JAMA · 2013 · Q1 · SJR 5.00 · FWCI 494.08 · 8,015 citations
New guidelines recommend treating adults 60+ to a BP goal of <150/90 mmHg, and those 30-59 to a diastolic goal of <90 mmHg, based on strong evidence. For younger adults or those under 30, a goal of <140/90 mmHg is recommended based on expert opinion due to insufficient evidence.
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Hypertension · 2017 · Q1 · SJR 3.00 · FWCI 483.22 · 7,395 citations
This report presents the 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults, developed through collaboration with multiple professional organizations.
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
Circulation · 2018 · Q1 · SJR 8.00 · FWCI 715.67 · 7,224 citations
This report compiles the latest statistics on heart disease, stroke, and related cardiovascular risk factors from leading health organizations.
2018 ESC/EACTS Guidelines on myocardial revascularization
European Heart Journal · 2018 · Q1 · SJR 5.00 · FWCI 499.25 · 7,156 citations · Open access
These guidelines provide a comprehensive summary and evaluation of current evidence to assist physicians in selecting optimal management strategies for myocardial revascularization.
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
Circulation · 2014 · Q1 · SJR 8.00 · FWCI 567.60 · 7,151 citations · Open access
This document presents the official 2014 clinical practice guidelines for managing patients with atrial fibrillation, developed by the American Heart Association, American College of Cardiology, and Heart Rhythm Society.
Recently added
2025 ESC/EACTS Guidelines for the management of valvular heart disease
European Heart Journal · 2025 · Q1 · SJR 5.00 · FWCI 595.12 · 823 citations · Open access
These new ESC/EACTS Guidelines provide updated recommendations for managing valvular heart disease, reflecting the latest scientific and medical knowledge.
2023 ESC Guidelines for the management of acute coronary syndromes
European Heart Journal · 2023 · Q1 · SJR 5.00 · FWCI 840.66 · 4,676 citations · Open access
The 2023 ESC Guidelines introduce a new risk stratification tool, the ACS Score, which integrates clinical, ECG, and biomarker data to predict mortality risk in acute coronary syndromes (ACS) more accurately than existing methods.
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Journal of Hypertension · 2023 · Q1 · SJR 1.00 · FWCI 564.22 · 3,131 citations
The 2023 European Society of Hypertension (ESH) guidelines introduce a simplified approach to managing arterial hypertension, emphasizing office blood pressure (BP) measurement and home BP monitoring (HBPM) for diagnosis and treatment assessment.
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Circulation · 2023 · Q1 · SJR 8.00 · FWCI 863.70 · 5,966 citations
The American Heart Association's 2023 Statistical Update provides the latest data on heart disease, stroke, and related risk factors, including core health behaviors and health factors, with an enhanced focus on health equity and COVID-19 impacts.
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
European Heart Journal · 2022 · Q1 · SJR 5.00 · FWCI 371.15 · 2,926 citations
The 2022 ESC Guidelines introduce a new risk stratification tool for sudden cardiac death (SCD) in patients with ventricular arrhythmias (VAs), incorporating genetic testing and advanced imaging.
Add this field to your daily feed
Pick your interests and new work in your area arrives every day, summarised. Full summaries live in the app.
Open the app